GLID方案治疗NK／T细胞淋巴瘤8例临床分析
摘要
NK／T细胞淋巴瘤是一种少见特殊类型的非霍奇金淋巴瘤，其发病与EB病毒密切相关。组织病理表现为肿瘤细胞噬血管性、血管坏死及炎性细胞浸润，侵袭性高，为进行性、破坏性病变，且常伴发噬血细胞综合征，故预后差，严重威胁患者的生命。其对放疗敏感，对化疗中低度敏感，目前尚无统一有效的治疗方法，死亡率高，长期生存率低。
出处
《临床内科杂志》
CAS
2015年第2期118-119,共2页
Journal of Clinical Internal Medicine
参考文献10
-
1吴欢欢,卫青,王旖旎,王昭.NK／T细胞淋巴瘤继发噬血细胞综合征一例[J].临床内科杂志,2012,29(2):139-139. 被引量：1
-
2Vose J, Armitage J,Weisenburger D. International peripheral T-cell andnatural killer/T-cell lymphoma study : pathology findings and clinicaloutcomes[ J]. J Clin Oncol,2008,26 (25 ) :41244130.
-
3Yamaguchi M,Tobinai K, Oguchi M. et al. Phase I/II study of concur-rent chemoradiotherapy for localized nasal natural killer/T-cell lympho-ma :Japan Clinical Oncology Group Study JCOG0211 [ J]. J Clin Oncol,2009,27(33):5594-5600.
-
4Wang B,Li XQ,Ma X,et al. Immunohistochemical expression and clini-cal significance of P-glycoprotein in previously untreated extranodalNK/T-cell lymphoma,nasal type [ J]. Am J Hematol,2008 ,83 ( 10 ):795-799.
-
5Yong W, Zheng W,Zhu J, et al. Midline NK/T-cell lymphoma nasal-type :treatment outcome, the effect of L-asparaginase based regimen, andprognostic factors[ J]. Hematol Oncol,2006,24( 1 ) :28-32.
-
6Yong W,Zheng W,Zhu J,et al. L-asparaginase in the treatment of re-fractory and relapsed extranodal NK/T-cell lymphoma,nasal type [ J ].Ann Hematol,2009,88(7) :647-652.
-
7Reyes VE,Jr Al-Saleem T,Robu VG,et al. Extranodal NK/T-cell lym-phoma nasal type : efficacy of pegaspargase. Report of two patients fromthe United Sates and review of literature[ J]. Leuk Res,2010,34( 1 ):e50-54.
-
8Kim SJ,Yang DH,Kim JS,et al. Concurrent chemoradiotherapy followedby L-asparaginase-containing chemotherapy, VIDL, for localized nasalextranodal NK/T cell lymphoma: CISL08-01 phase II study [ J ]. AnnHematol,2014,93( 11) :1895-1901.
-
9Yamaguchi M,Suzuki R,Kwong YL,et al. Phase I study of dexametha-sone,methotrexate,ifosfamide,L-asparaginase,and etoposide ( SMILE )chemotherapy for advanced-stage, relapsed or refractory extranodal natu-ral killer( NK)/T-cell lymphoma and leukemia[ J]. Cancer Sci,2008 ,99(5);1016-1020.
-
10Ahn HK,Kim SJ,Hwang DW,et al. Gemcitabine alone and/or contai-ning chemotherapy is efficient in refractory or relapsed NK/T-celllymphoma[ J]. Invest New Drugs,2013 ,31 (2) :469-472.
二级参考文献6
-
1Yiu CR,Kao YH,Phipps C,et al.Positron emission tomography findings in patients with lymphoma-associated hemophagocytic syndrome.Singapore Med J,2011,52:156-159.
-
2Kumar A,Dutta R,Kannan U,et al.Evaluation of mediastinal lymph nodes using 18F-FDG PET-CT scan and its histopathologic correlation.Ann Thorac Med,2011,6:11-16.
-
3Tsagarakis NJ,Kentrou NA,Kakiopoulos G,et al.Flow cytometry as a diagnostic tool in the early diagnosis of aggressive lymphomas mimicking life-threatening infection.Case Report Med,2011 ;2011:743817.
-
4Tong H,Ren Y,Liu H,et al.Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome:comparison of T-cell lymphoma with and without hemophagocytic syndrome.Leukemia and Lymphoma,2008,49:81-87.
-
5王昭,王旖旎,冯翠翠,田莉萍,陈皙.继发性噬血细胞性淋巴组织细胞增多症57例患者的早期诊断和临床分析[J].中华内科杂志,2009,48(4):312-315. 被引量：9
-
6王晓琳(综述),王昭(审校).淋巴瘤相关噬血细胞综合征的诊断与治疗进展[J].白血病．淋巴瘤,2010,19(10):632-634. 被引量：10
-
1田振华,董龙宝,李刚强,薛洁,王正茂,许可.鼻型NKT淋巴瘤患者血清生存素和P53表达及其临床意义研究[J].实用癌症杂志,2016,31(12):1919-1921.
-
2常占国,徐全晓,贺利民,马磊.左旋门冬酰胺酶在鼻型NK/T淋巴瘤治疗中的疗效观察[J].中国社区医师（医学专业）,2013,15(2):85-85.
-
3彭丽萍,李进,胡夕春.19例原发鼻腔非NK/T淋巴瘤的临床分析[J].临床肿瘤学杂志,2007,12(11):819-821.
-
4王莉.左旋门冬酰胺酶联合GEMOX方案治疗鼻型NK/T淋巴瘤的疗效观察[J].黑龙江医学,2014,38(2):163-164. 被引量：7
-
5祝朝富,黄洪婕.60例早期鼻腔NK/T淋巴瘤放疗疗效观察[J].中国民族民间医药,2009,18(7):109-109.
-
6茹欢孟,吴利江.MRI在骨巨细胞瘤诊断中的意义[J].浙江医学,2007,29(8):880-881. 被引量：1
-
7袁珂,沈鹏臻.大肠原发性NK/T细胞淋巴瘤诊断分析[J].四川医学,2013,34(10):1535-1537.
-
8彭志强,董涵之,双跃荣.含培门冬酶的化疗方案治疗淋巴瘤的安全性分析[J].江西医药,2016,51(6):507-510. 被引量：5
-
9聂大红,谢方云,李济时,刘宜敏,伍勇.早期鼻腔NK/T细胞淋巴瘤治疗方法和预后分析[J].中华放射肿瘤学杂志,2010,19(4):315-319. 被引量：5
-
10陈俊,郭建新,陶庆松,黄佳,王碧云.20例鼻NK/T淋巴瘤放化疗疗效分析[J].肿瘤学杂志,2007,13(3):231-232. 被引量：1
